Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?

Sebastian N MarschnerCornelius MaihöferRichard SpäthErik HaehlDaniel ReitzNora KienlechnerLars SchüttrumpfPhilipp BaumeisterUlrike PflugradtJulia HeßHorst ZitzelsbergerKristian UngerClaus BelkaFranziska Walter

Published in: Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (2024)

ACE-27 and ASA score effectively categorize patients' risks in adjuvant radiotherapy for head and neck cancer, proving more predictive of overall survival than ECOG-PS. These results underscore the importance of objective comorbidity assessment and suggest further prospective studies.

Keyphrases

early stage
locally advanced
end stage renal disease
radiation therapy
ejection fraction
chronic kidney disease
radiation induced
photodynamic therapy
prognostic factors
squamous cell carcinoma
rectal cancer
risk assessment
cancer therapy
case control
patient reported